We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

By LabMedica International staff writers
Posted on 22 Jul 2014
Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.

Investigators at Duke University (Durham, NC, USA) fed different groups of mice either a diet rich in saturated fatty acids (SFAs), omega-6 polyunsaturated FAs (PUFAs), or omega-6 PUFAs supplemented with omega-3 PUFAs. More...
OA was induced by destabilizing the medial meniscus. Wound healing was evaluated using an ear punch. OA, synovitis, and wound healing were determined histologically, while bone changes were measured using microCT (computerized tomography).

Results published in the July 10, 2014, online edition of the journal Annals of the Rheumatic Diseases revealed that OA was significantly associated with dietary fatty acid content and serum adipokine levels, but not with body weight. Furthermore, spontaneous activity of the mice was independent of OA development. Small amounts of omega-3 PUFAs (8% by kilocalorie) in a high-fat diet were sufficient to mitigate injury-induced OA. Omega-3 PUFAs significantly enhanced wound repair, while SFAs or omega-6 PUFAs independently increased OA severity, ossification, and scar tissue formation.

“Our results suggest that dietary factors play a more significant role than mechanical factors in the link between obesity and osteoarthritis,” said senior author Dr. Farshid Guilak, professor of orthopedic surgery at Duke University. “While omega-3 fatty acids are not reversing the injury, they appear to slow the progression of arthritis in this group of mice. In fact, omega-3 fatty acids eliminated the detrimental effects of obesity in obese mice. A great next step would be to do a clinical study to look at effect of omega-3 fatty acids post-injury.”


Related Links:
Duke University



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.